David J. Bearss
Angel · Utah
Board director at 2 startups that filed Form D raises since late 2024, mostly in Utah.
- Stages
- Series A
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jul 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Biolexis TherapeuticsOct 3, 2023
- SEC Form D: Halia TherapeuticsJul 16, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.